MAPT and Alzheimer disease: To test whether euphpepluone K (9) has potential biological activity against Tau pathology, cellular analysis was conducted by using a cellular AD model created by the authors: human glioma U251 cells stably expressing the human MAPT mutant (MAPT p.P301S) (U251-MAPT P301S cells).